Literature DB >> 8037499

Hypersensitivity to molybdenum as a possible trigger of ANA-negative systemic lupus erythematosus.

M Federmann1, B Morell, G Graetz, M Wyss, P Elsner, R von Thiessen, B Wüthrich, D Grob.   

Abstract

After implantation of two metal plates a 24 year old woman developed fever of unknown origin and successively more symptoms of an ANA-negative systemic lupus erythematosus (SLE). These symptoms resolved after removal of the plates and recurred during patch testing of the metal components, which showed a reaction to molybdenum. A lymphocyte transformation test indicated a delayed-type hypersensitivity to molybdenum. Subsequent progressive flare ups of SLE appeared without molybdenum reexposure. This is the first report suggesting the existence of a hypersensitivity to molybdenum, which may act as another environmental trigger for SLE.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037499      PMCID: PMC1005357          DOI: 10.1136/ard.53.6.403

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

Review 1.  B-cell responses in autoimmune diseases.

Authors:  C Boitard
Journal:  Curr Opin Immunol       Date:  1992-12       Impact factor: 7.486

2.  Exacerbation of lupus erythematosus following splenectomy in idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia.

Authors:  W DAMESHEK; W H REEVES
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

3.  Could splenectomy worsen autoimmune manifestations?

Authors:  P Cales; M Howaizi; J P Vinel; J P Pascal
Journal:  J Intern Med       Date:  1990-10       Impact factor: 8.989

4.  Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-1980.

Authors:  E B Larson; H J Featherstone; R G Petersdorf
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters.

Authors:  F A Barada; B S Andrews; J S Davis; R P Taylor
Journal:  Arthritis Rheum       Date:  1981-10

7.  Serological findings in patients with "ANA-negative" systemic lupus erythematosus.

Authors:  P J Maddison; T T Provost; M Reichlin
Journal:  Medicine (Baltimore)       Date:  1981-03       Impact factor: 1.889

Review 8.  NIH conference. Systemic lupus erythematosus.

Authors:  A D Steinberg; M F Gourley; D M Klinman; G C Tsokos; D E Scott; A M Krieg
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

9.  Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.

Authors:  M C Hochberg; R E Boyd; J M Ahearn; F C Arnett; W B Bias; T T Provost; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1985-09       Impact factor: 1.889

10.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

View more
  2 in total

1.  Th1 type lymphocyte reactivity to metals in patients with total hip arthroplasty.

Authors:  Nadim James Hallab; Marco Caicedo; Alison Finnegan; Joshua J Jacobs
Journal:  J Orthop Surg Res       Date:  2008-02-13       Impact factor: 2.359

2.  Do Battlefield Injury-acquired Indwelling Metal Fragments Induce Metal Immunogenicity?

Authors:  Lauryn Samelko; Joseph Petfield; Kyron McAllister; Joseph Hsu; Michael Hawkinson; Joshua J Jacobs; Nadim J Hallab
Journal:  Clin Orthop Relat Res       Date:  2020-04       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.